UAE Oncology Based Molecular Diagnostics Market Size & Outlook

The oncology based molecular diagnostics market in the UAE is expected to reach a projected revenue of US$ 34.6 million by 2030. A compound annual growth rate of 6.6% is expected of the UAE oncology based molecular diagnostics market from 2025 to 2030.
Revenue, 2024 (US$M)
$23.2
Forecast, 2030 (US$M)
$34.6
CAGR, 2025 - 2030
6.6%
Report Coverage
UAE

UAE oncology based molecular diagnostics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UAE oncology based molecular diagnostics market, 2018-2030 (US$M)

Related Markets

UAE oncology based molecular diagnostics market highlights

  • The UAE oncology based molecular diagnostics market generated a revenue of USD 23.2 million in 2024 and is expected to reach USD 34.6 million by 2030.
  • The UAE market is expected to grow at a CAGR of 6.6% from 2025 to 2030.
  • In terms of segment, breast cancer was the largest revenue generating type in 2024.
  • Breast Cancer is the most lucrative type segment registering the fastest growth during the forecast period.

Oncology based molecular diagnostics market data book summary

Market revenue in 2024USD 23.2 million
Market revenue in 2030USD 34.6 million
Growth rate6.6% (CAGR from 2025 to 2030)
Largest segmentBreast cancer
Fastest growing segmentBreast Cancer
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBreast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer
Key market players worldwideAbbott Laboratories, Bayer AG, Agilent Technologies Inc, Danaher Corp, Hologic Inc, Qiagen NV, Siemens AG, Sysmex Corp, Becton Dickinson & Co, Roche Holding AG ADR

Other key industry trends

  • In terms of revenue, UAE accounted for 0.6% of the global oncology based molecular diagnostics market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa oncology based molecular diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 34.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Oncology based Molecular Diagnostics Market Companies

Name Profile # Employees HQ Website

UAE oncology based molecular diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oncology based molecular diagnostics market will help companies and investors design strategic landscapes.


Breast cancer was the largest segment with a revenue share of 21.12% in 2024. Horizon Databook has segmented the UAE oncology based molecular diagnostics market based on breast cancer, prostate cancer, colorectal cancer, cervical cancer, liver cancer, lung cancer, blood cancer, kidney cancer covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to UAE oncology based molecular diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UAE oncology based molecular diagnostics market databook

  • Our clientele includes a mix of oncology based molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UAE oncology based molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into UAE oncology based molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UAE oncology based molecular diagnostics market size, by type, 2018-2030 (US$M)

UAE Oncology based Molecular Diagnostics Market Outlook Share, 2024 & 2030 (US$M)

UAE oncology based molecular diagnostics market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more